BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03355976 |
|
Recruitment Status :
Recruiting
First Posted : November 29, 2017
Last Update Posted : August 3, 2020
|
Sponsor:
Don Dizon
Collaborators:
Bristol-Myers Squibb
Rhode Island Hospital
The Miriam Hospital
Brown University
Women and Infants Hospital of Rhode Island
Information provided by (Responsible Party):
Don Dizon, Brown University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | February 2021 |
| Estimated Study Completion Date : | February 2023 |